PRESS RELEASE
Aug 21, 2026
BioStem Technologies Eyes Surgical Growth, Manufacturing Shift After BioTissue Deal
Aug 14, 2026
BioStem Technologies to Present at the Sidoti MicroCap Conference
Aug 13, 2026
BioStem Technologies Q2 Earnings Call Highlights
Aug 12, 2026
BioStem Technologies, Inc. (BSEM) Q2 2026 Earnings Call Transcript
Aug 12, 2026
BioStem Technologies, Inc. (BSEM) Reports Q2 Loss, Beats Revenue Estimates
Aug 12, 2026
BioStem Technologies Reports Second Quarter 2026 Financial Results
Aug 06, 2026
BioStem Technologies Announces Nasdaq Uplisting
Jul 30, 2026
BioStem Technologies to Host Second Quarter 2026 Financial Results Conference Call on August 12, 2026
Jul 10, 2026
BioStem Technologies Publicly Files Form 10 Registration Statement with the Securities and Exchange Commission
Jul 08, 2026
BioStem Technologies Announces Issuance of Four U.S. Design Patents Covering Fenestrated Human Placental Allograft Technologies